SHIFT Newsroom · GLOBAL

GLP-1 prescribing patterns: research preprint

A preprint examines obesity and GLP-1 prescribing in a large integrated health system. It has not been peer reviewed.

By SHIFT AI Newsroom · Published 13 September 2026

This preprint examines clinical characteristics and prescribing patterns in a large integrated health system during the GLP-1 era.

It has not been peer reviewed. Findings from one health system cannot establish UK prescribing practice or a change to NHS access.

SHIFT’s take

What we think this could mean for you, and what remains uncertain.

This research may have implications for the management of obesity in the UK, particularly in relation to GLP-1 therapies

A study has been published on obesity in the GLP-1 era, examining clinical characteristics and prescribing patterns in a large integrated health system